200 related articles for article (PubMed ID: 33110151)
1. Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Cacciante F; Gennaro M; Sagona G; Mazziotti R; Lupori L; Cerri E; Putignano E; Butt M; Do MT; McKew JC; Alessandrì MG; Battini R; Cioni G; Pizzorusso T; Baroncelli L
Sci Rep; 2020 Oct; 10(1):18361. PubMed ID: 33110151
[TBL] [Abstract][Full Text] [Related]
2. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
3. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
[TBL] [Abstract][Full Text] [Related]
4. Creatine Transporter Deficiency in Two Brothers with Autism Spectrum Disorder.
Aydin HI
Indian Pediatr; 2018 Jan; 55(1):67-68. PubMed ID: 29396939
[TBL] [Abstract][Full Text] [Related]
5. A Nervous System-Specific Model of Creatine Transporter Deficiency Recapitulates the Cognitive Endophenotype of the Disease: a Longitudinal Study.
Molinaro A; Alessandrì MG; Putignano E; Leuzzi V; Cioni G; Baroncelli L; Pizzorusso T
Sci Rep; 2019 Jan; 9(1):62. PubMed ID: 30635645
[TBL] [Abstract][Full Text] [Related]
6. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
[TBL] [Abstract][Full Text] [Related]
7. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.
Ghirardini E; Calugi F; Sagona G; Di Vetta F; Palma M; Battini R; Cioni G; Pizzorusso T; Baroncelli L
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440297
[TBL] [Abstract][Full Text] [Related]
8. A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.
Duran-Trio L; Fernandes-Pires G; Simicic D; Grosse J; Roux-Petronelli C; Bruce SJ; Binz PA; Sandi C; Cudalbu C; Braissant O
Sci Rep; 2021 Jan; 11(1):1636. PubMed ID: 33452333
[TBL] [Abstract][Full Text] [Related]
9. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
[TBL] [Abstract][Full Text] [Related]
10. [A family with creatine transporter deficiency diagnosed with urinary creatine/creatinine ratio and the family history: the third Japanese familial case].
Nozaki F; Kumada T; Shibata M; Fujii T; Wada T; Osaka H
No To Hattatsu; 2015 Jan; 47(1):49-52. PubMed ID: 25803912
[TBL] [Abstract][Full Text] [Related]
11. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.
Ullio-Gamboa G; Udobi KC; Dezard S; Perna MK; Miles KN; Costa N; Taran F; Pruvost A; Benoit JP; Skelton MR; Lonlay P; Mabondzo A
Nanomedicine (Lond); 2019 Jun; 14(12):1579-1593. PubMed ID: 31038003
[TBL] [Abstract][Full Text] [Related]
12. Creatine transporter deficiency, an underdiagnosed cause of male intellectual disability.
Jangid N; Surana P; Salmonos G; Jain V
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334757
[TBL] [Abstract][Full Text] [Related]
13. Creatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case.
Thurm A; Himelstein D; DʼSouza P; Rennert O; Jiang S; Olatunji D; Longo N; Pasquali M; Swedo S; Salomons GS; Carrillo N
J Dev Behav Pediatr; 2016 May; 37(4):322-6. PubMed ID: 27096572
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging.
Baroncelli L; Molinaro A; Cacciante F; Alessandrì MG; Napoli D; Putignano E; Tola J; Leuzzi V; Cioni G; Pizzorusso T
Hum Mol Genet; 2016 Oct; 25(19):4186-4200. PubMed ID: 27466184
[TBL] [Abstract][Full Text] [Related]
15. Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Passi GR; Pandey S; Devi ARR; Konanki R; Jain AR; Bhatnagar S; Tripathi R; Jain V
Brain Dev; 2022 Apr; 44(4):271-280. PubMed ID: 34974949
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Creatine Transporter (SLC6A8) Deficiency With Oral S-Adenosyl Methionine as Adjunct to L-arginine, Glycine, and Creatine Supplements.
Jaggumantri S; Dunbar M; Edgar V; Mignone C; Newlove T; Elango R; Collet JP; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
Pediatr Neurol; 2015 Oct; 53(4):360-363.e2. PubMed ID: 26205312
[TBL] [Abstract][Full Text] [Related]
17. X-linked creatine transporter deficiency: clinical aspects and pathophysiology.
van de Kamp JM; Mancini GM; Salomons GS
J Inherit Metab Dis; 2014 Sep; 37(5):715-33. PubMed ID: 24789340
[TBL] [Abstract][Full Text] [Related]
18. Inborn errors of creatine metabolism and epilepsy.
Leuzzi V; Mastrangelo M; Battini R; Cioni G
Epilepsia; 2013 Feb; 54(2):217-27. PubMed ID: 23157605
[TBL] [Abstract][Full Text] [Related]
19. Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits.
Hautman ER; Kokenge AN; Udobi KC; Williams MT; Vorhees CV; Skelton MR
J Inherit Metab Dis; 2014 Jan; 37(1):63-8. PubMed ID: 23716276
[TBL] [Abstract][Full Text] [Related]
20. Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder.
Yıldız Y; Göçmen R; Yaramış A; Coşkun T; Haliloğlu G
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
